Published in Inflamm Bowel Dis on December 01, 2013
Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis. Am J Physiol Gastrointest Liver Physiol (2015) 0.81
Matrine alleviates lipopolysaccharide-induced intestinal inflammation and oxidative stress via CCR7 signal. Oncotarget (2017) 0.77
ClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic target. Tissue Barriers (2015) 0.75
Chloride channel ClC- 2 enhances intestinal epithelial tight junction barrier function via regulation of caveolin-1 and caveolar trafficking of occludin. Exp Cell Res (2017) 0.75
Hydrogen sulfide from a NaHS source attenuates dextran sulfate sodium (DSS)-induced inflammation via inhibiting nuclear factor-κB. J Zhejiang Univ Sci B (2016) 0.75
Genistein improves inflammatory response and colonic function through NF-κB signal in DSS-induced colonic injury. Oncotarget (2017) 0.75
Chemically induced mouse models of intestinal inflammation. Nat Protoc (2007) 8.65
Intestinal mucosal barrier function in health and disease. Nat Rev Immunol (2009) 7.15
CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit Rev Biochem Mol Biol (2008) 5.03
Occludin is a functional component of the tight junction. J Cell Sci (1996) 3.90
A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol (1997) 3.86
Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet (1993) 3.42
Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol (2006) 2.94
Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol (2005) 2.92
Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol (2010) 2.47
Amazing chloride channels: an overview. Acta Physiol Scand (2003) 2.42
Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology (1999) 2.37
Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut (2008) 2.30
Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest (2006) 2.00
Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption. EMBO J (2001) 1.86
Expression of the chloride channel ClC-2 in the murine small intestine epithelium. Am J Physiol Cell Physiol (2000) 1.75
Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci (2003) 1.70
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest (2008) 1.64
Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol (2011) 1.48
Functional evaluation of human ClC-2 chloride channel mutations associated with idiopathic generalized epilepsies. Physiol Genomics (2004) 1.37
Loss of hyperpolarization-activated Cl(-) current in salivary acinar cells from Clcn2 knockout mice. J Biol Chem (2002) 1.34
Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol (2000) 1.29
Occludin is required for cytokine-induced regulation of tight junction barriers. J Cell Sci (2010) 1.26
Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J Biol Chem (2009) 1.21
Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res (2007) 1.20
Stimulus-induced reorganization of tight junction structure: the role of membrane traffic. Biochim Biophys Acta (2007) 1.18
Changes in the expression of claudins in active ulcerative colitis. J Gastroenterol Hepatol (2008) 1.17
Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World J Gastroenterol (2011) 1.05
ClC-2 chloride secretion mediates prostaglandin-induced recovery of barrier function in ischemia-injured porcine ileum. Gastroenterology (2004) 1.03
Apical junction complex protein expression in the canine colon: differential expression of claudin-2 in the colonic mucosa in dogs with idiopathic colitis. J Histochem Cytochem (2007) 0.93
ClC-2 regulates mucosal barrier function associated with structural changes to the villus and epithelial tight junction. Am J Physiol Gastrointest Liver Physiol (2010) 0.93
Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis. FEBS J (2007) 0.93
Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin. Am J Physiol Cell Physiol (2011) 0.93
ClC-2 is required for rapid restoration of epithelial tight junctions in ischemic-injured murine jejunum. Exp Cell Res (2008) 0.91
Prostaglandin-mediated inhibition of Na+/H+ exchanger isoform 2 stimulates recovery of barrier function in ischemia-injured intestine. Am J Physiol Gastrointest Liver Physiol (2006) 0.89
Severe defects in absorptive ion transport in distal colons of mice that lack ClC-2 channels. Gastroenterology (2011) 0.87
Endocytosis and recycling of tight junction proteins in inflammation. J Biomed Biotechnol (2010) 0.86
Building better bugs to deliver biologics in intestinal inflammation. Gut (2010) 0.85
Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells. J Biol Chem (2010) 0.83
Crosstalk between Rab GTPases and cell junctions. Contraception (2005) 0.81
Chloride channels and tight junctions. Focus on "Expression of the chloride channel ClC-2 in the murine small intestine epithelium". Am J Physiol Cell Physiol (2000) 0.76
Two-dimensional nanosheets produced by liquid exfoliation of layered materials. Science (2011) 6.00
Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology (2008) 3.89
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis (2008) 2.08
Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine. Histochem Cell Biol (2005) 1.94
Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med (2005) 1.90
Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110δ. Gastroenterology (2010) 1.80
Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem (2007) 1.71
Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci (Landmark Ed) (2009) 1.57
The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum (2005) 1.51
Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol (2004) 1.50
Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. J Biol Chem (2003) 1.49
Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol (2011) 1.48
Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect. Pediatrics (2004) 1.46
Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J Leukoc Biol (2009) 1.45
Applying an artificial neural network to warfarin maintenance dose prediction. Isr Med Assoc J (2004) 1.43
Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol (2007) 1.42
Fecal Microbiota Transplantation for Clostridium difficile-Associated Diarrhea. Isr Med Assoc J (2015) 1.39
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J Clin Invest (2003) 1.33
An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J Immunol (2011) 1.31
NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunity. J Immunol (2011) 1.25
Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. J Immunol (2010) 1.23
Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J Immunol (2007) 1.22
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. J Immunol (2007) 1.21
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 1.20
Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum (2006) 1.17
The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis (2014) 1.13
Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach. J Clin Virol (2010) 1.06
Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J Biol Chem (2002) 1.05
Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility. J Mol Cell Cardiol (2004) 1.05
The role of the macrophage in sentinel responses in intestinal immunity. Curr Opin Gastroenterol (2010) 1.03
Dosage adjustment during long-term adalimumab treatment for Crohn's disease: clinical efficacy and pharmacoeconomics. Inflamm Bowel Dis (2011) 1.03
CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system. Inflamm Bowel Dis (2010) 1.02
IL-10 regulates Il12b expression via histone deacetylation: implications for intestinal macrophage homeostasis. J Immunol (2012) 0.99
Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance. Gastroenterology (2012) 0.98
Inflammatory pseudotumor of the liver associated with Crohn's disease. J Clin Gastroenterol (2004) 0.98
Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda. Inflamm Bowel Dis (2013) 0.97
NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis. J Immunol (2014) 0.92
A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis. PLoS One (2012) 0.92
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis (2010) 0.92
BRCA1/2 mutation analysis in male breast cancer families from North West England. Fam Cancer (2007) 0.90
The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74. J Immunol (2011) 0.89
Parasite killing in malaria non-vector mosquito Anopheles culicifacies species B: implication of nitric oxide synthase upregulation. PLoS One (2011) 0.89
Innate PI3K p110δ regulates Th1/Th17 development and microbiota-dependent colitis. J Immunol (2014) 0.87
Characterization of an interferon-stimulated response element (ISRE) in the Il23a promoter. J Biol Chem (2010) 0.85
Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice. Inflamm Bowel Dis (2013) 0.85
High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals. Gut Microbes (2015) 0.84
Salivary gland transcriptome analysis in response to sugar feeding in malaria vector Anopheles stephensi. J Insect Physiol (2011) 0.83
Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease. Inflamm Bowel Dis (2013) 0.83
Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? Inflamm Bowel Dis (2005) 0.82
Gastro protective properties of the novel prostone SPI-8811 against acid-injured porcine mucosa. World J Gastroenterol (2012) 0.81
Kidney, blood, and endothelium: developmental expression of stem cell leukemia during nephrogenesis. Kidney Int (2004) 0.81
Intestinal ribosomal p70(S6K) signaling is increased in piglet rotavirus enteritis. Am J Physiol Gastrointest Liver Physiol (2006) 0.81
A Crohn's disease patient who does not respond to infliximab: what is next? Clin Gastroenterol Hepatol (2011) 0.81
Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis. Digestion (2006) 0.81
The role of endothelin converting enzyme inhibition during group B streptococcus-induced pulmonary hypertension in newborn piglets. Pediatr Res (2003) 0.81
Microtubule-associated serine/threonine kinase-205 kDa and Fc gamma receptor control IL-12 p40 synthesis and NF-kappa B activation. J Immunol (2004) 0.81
"PhacoTracking": an evolving paradigm in ophthalmic surgical training. JAMA Ophthalmol (2013) 0.80
Newborn girl with massive hepatomegaly, anemia, and thrombocytopenia. J Pediatr (2008) 0.80
Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice. Endocrinology (2014) 0.79
High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. J Clin Gastroenterol (2016) 0.78
In vitro and in vivo evaluation of a water-in-oil microemulsion system for enhanced peptide intestinal delivery. AAPS J (2012) 0.77
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience. Inflamm Bowel Dis (2017) 0.76
Novel role for surfactant protein A in gastrointestinal graft-versus-host disease. J Immunol (2012) 0.76
Views conclusions in ultrasound study as unsupported. J Am Vet Med Assoc (2006) 0.75
Possible transmission of human immunodeficiency virus-1 infection from an elite controller to a patient who progressed to acquired immunodeficiency syndrome: a case report. J Med Case Rep (2012) 0.75
Pericardial effusion of obscure origin. Dig Dis Sci (2014) 0.75
Farm animals and inflammatory bowel disease: old MacDonald had poor hygiene. Gastroenterology (2008) 0.75
Poorly responsive ulcerative colitis in the hospital. Clin Gastroenterol Hepatol (2009) 0.75
CD151 Regulates T-Cell Migration in Health and Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.75
Role of nonsteroidal anti-inflammatory drugs in gastrointestinal tract injury and repair. J Am Vet Med Assoc (2003) 0.75
Dr Peter Rossdale, OBE, Editor Equine Veterinary Journal 1980-2010. Equine Vet J (2011) 0.75
Reye's syndrome in a 17-year-old male: is this disease really disappearing? Dig Dis Sci (2002) 0.75
The evaluation of bony union after frontofacial distraction. J Craniofac Surg (2009) 0.75
Cyclooxygenase blockade and exogenous glutamine enhance sodium absorption in infected bovine ileum. Am J Physiol Gastrointest Liver Physiol (2002) 0.75
Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med (2017) 0.75
The use of botanical products and vitamins in sunscreens. Dermatol Online J (2015) 0.75
[Use of fecal microbial transplantations for disease states in Israel]. Harefuah (2015) 0.75
[Autoimmune hepatitis]. Harefuah (2009) 0.75
Acute fatty liver of pregnancy treated with plasma exchange. Dig Dis Sci (2014) 0.75
Designating staff to collect payment before surgery. MGMA Connex (2015) 0.75
Erratum: NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nat Immunol (2017) 0.75
Cecal impaction in horses. Compend Contin Educ Vet (2011) 0.75
Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses. J Am Vet Med Assoc (2017) 0.75
Prediction of growth and biotransformation rates of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in the presence of barium. Appl Microbiol Biotechnol (2005) 0.75
Corrigendum: NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nat Immunol (2017) 0.75